A Peek at Aquestive Therapeutics

I think genomics and many aspects of the bio-tech world will be a major force in our world over the next decade. Given this, I view this arena as a space to make wide ranging investments in to achieve high returns over the next decade. The convergence of artificial intelligence, DNA sequencing and gene editing, is extremely powerful housing the ability to cure diseases. 

One of our readers Susan requested we take a look at Aquestive Therapeutics, a company which we hold small stock position in. Word on the street is that Aquestive, which trades on the NASDAQ under the symbol AQST, is poised for a big run. We, let’s take a look and see if we can get a good read on Aquestive.